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Supramolecular protection from the enzymatic
tyrosine phosphorylation in a polypeptide†
Enrico Faggi,a Yolanda Pe´rez,b Santiago V. Luis*c and Ignacio Alfonso*a
Here we report two new artificial pseudopeptidic cages that bind the
EYE peptide epitope in pure water at physiological pH (as studied
by fluorescence and NMR spectroscopies). The supramolecular com-
plexation of the Tyr residues eﬃciently precludes their subsequent
PTK-catalysed phosphorylation. Our results show a supramolecular
modulation of the PTK activity by competitive substrate caging.
The molecular recognition of peptides and proteins is a hot
topic in supramolecular chemistry, with important implica-
tions in chemical biology.1 However, the binding of peptides
in pure water and at neutral pH is still a challenging issue, due
to the competitive eﬀect of water and the flexibility of the
peptides in solution.2 Some examples using cucurbituril,3
cyclodextrin4 or calixarene5 receptors have been reported
mainly based on hydrophobic interactions that are favoured
in pure water. Following our research with pseudopeptides,6 we
have recently designed large pseudopeptidic cages as eﬃcient
receptors for dipeptides in organic or aqueous-organic solvents,
showing a good selectivity for the Ac–EY–OH sequence.7 This
selectivity is manifested in the differential binding of stereo-
isomers of the Ac–EY–OH dipeptide by CySer and CyThr cages
(Fig. 1).8 Binding studies using several spectroscopic techniques
with different dipeptides, combined with molecular mechanics
calculations allowed defining a mode of binding.7,8 The corres-
ponding host–guest complexes are stabilized by both polar (salt
bridges and H-bonds) and non-polar (p–p stacking) interactions,
where the encapsulation of the Tyr aromatic ring inside the cage
cavity plays an important role. The Tyr residue in polypeptides is
a biologically interesting target: for instance, the EYE sequence
is a well-known substrate epitope of protein tyrosine kinases
(PTKs),9 which catalyse the transfer of a phosphoryl group from
ATP to the Tyr hydroxyl group. This phosphorylation is an impor-
tant post-translational modification, being closely connected
with cell regulation, signalling and growth.10 Thus, the abnormal
function of PTKs is related to serious diseases, such as diabetes,11
cancer12 and neurodegenerative diseases.13 Therefore, there is
growing interest in the design and study of new molecules and
mechanisms to modulate kinase activity.‡
Inspired by the highly regulated action of PTK enzymes in
nature, we envisioned that artificial cages with good aﬃnity
for the corresponding peptidic substrates would form stable
supramolecular complexes, protecting the Tyr residues from
the phosphorylation action of the enzyme (Fig. 2). Here we
show that this supramolecular approach of PTK modulation can
be performed using synthetic pseudopeptidic cages as competi-
tive substrate binders.
To test our hypothesis, we used commercial poly(EY) as a
model for the PTK substrate.9 Poly(EY) is a random 20–50 kDa
copolymer with a 4 : 1 Glu : Tyr molar ratio to maximize the
occurrence of the EYE motif. Considering previous results,7,8
Fig. 1 Chemical structures of the pseudopeptidic cages, with the
assumed labelling.
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we designed two new hosts (CyOrn and CyLys, Fig. 1) with
positively charged side chains at neutral pH, to increase the
interaction with the anionic poly(EY). These new cages were
synthesized following a convenient modification of a reported
procedure14 (ESI†). The mechanism schematically proposed in
Fig. 2 is specially challenging from the supramolecular per-
spective since it requires a strong interaction between a non-
natural host (pseudopeptidic cages) and a highly solvated and
flexible polypeptide in pure water at neutral pH (as shown by
NMR and CD studies, see the ESI†). Moreover, the PTK–poly(EY)
contact can be considered a protein–protein interaction (PPI),
which is difficult to disrupt with synthetic small molecules.15
First, we studied the binding between poly(EY) and the cages by
fluorescence spectroscopy in buﬀered water (60 mM Tris buﬀer
at pH 7.3). The titration of poly(EY) with CyOrn produced the
quenching of the Tyr emission at 304 nm, and the growth of an
intense band at 385 nm, with a clear isoemissive point at 358 nm
(Fig. 3A). This lower energy band was assigned to the formation of a
CyOrn–poly(EY) complex through the Tyr residue encapsulation.16
The non-linear fitting of this band to a 1 :1 bindingmode rendered
a dissociation constant of Kd = 920 mM (Table 1, entry 1). The
commercial poly(EY) is a poly-disperse molecule containing many
EYE binding sites and, in principle, all of them could bind to
the cage. Accordingly, for the quantitative measurements, we
considered the concentration of the repeating units (E4Y) as the
binding species, since each repeating unit contains a Tyr residue.
Therefore, the Kd values here reported reflect the average affinity for
each EYE binding site, assuming a 1 : 1 host–guest stoichiometry.
As a confirmation of the proposed interaction, we studied the
binding of CyOrn to the tripeptide Ac–EYE–NH2 by fluorescence
spectroscopy, also rendering the appearance of the band at 385 nm
and a similar Kd = 1.17mM (entry 2 in Table 1). This result suggests
that most of the Tyr residues in poly(EY) are accessible to the cage
and that they behave as nearly independent binding sites.
The fluorescence titration of poly(EY) with CyLys produced
diﬀerent fluorescence emission spectra (Fig. 3B). A more complex
band at longer wavelength was observed upon the addition of the
cage. Thus, the emission spectra showed several maxima (375 nm,
420 nm and 450 nm), probably corresponding to the co-existence
of diﬀerent complexes. The non-linear fitting of the fluorescence
data rendered a slightly stronger interaction (Table 1, entry 3),
which was also confirmed by performing the titration experiments
with a minimal expression of the binding epitope Ac–EYE–NH2
(Table 1, entry 4). The different shape of the spectra with CyLys
could be due to a different protonation degree of the complexes,
since CyLys is more basic than CyOrn (see the ESI†). This
hypothesis was confirmed by performing additional titration
experiments at different pH (Table 1, entries 5 and 6), which
Fig. 2 Schematic representation of the proposed mechanism: the binding
of the pseudopeptidic cage to the poly(EY) polypeptide protects the Tyr
residues (blue hexagons in the cartoon) from the further phosphorylation
mediated by PTK. Fig. 3 Binding of cages to EYE peptides: normalized fluorescence spectra
(lexc = 276 nm) of poly(EY) (60 mM Tris buﬀer, pH 7.3 at 25 1C) upon the
addition of the cages: (A) 2 104 M poly(EY) titrated with 0–1.33 103 M
CyOrn or (B) 4  105 M poly(EY) titrated with 0–3.3  104 M CyLys.
(C) Partial T1r-filtered
1H NMR spectra of CyOrn (0.4 mM in D2O, 75 mM Tris
buffer, pD 7.4 at 25 1C) alone (lower trace) and with increasing amounts of
poly(EY) (upper traces, 0.45 mM and 0.75 mM poly(EY), respectively). Signals
marked with (*) correspond to the poly(EY). In all the cases the concen-
tration of poly(EY) refers to the concentration of the repeating unit, E4Y.
Table 1 Dissociation constants (Kd, mM) for the interaction between the
cages and diﬀerent peptides in buﬀered water at 25 1C
Entry Cage Peptide pH Kd
a (mM)
1 CyOrn Poly(EY) 7.3 920b
2 CyOrn Ac–EYE–NH2 7.3 1170
b
3 CyLys Poly(EY) 7.3 450b
4 CyLys Ac–EYE–NH2 7.3 570
b
5 CyLys Poly(EY) 5.3 140b
6 CyLys Poly(EY) 8.7 440b
7 CyOrn Poly(EY) 7.4 (pD) 403c
8 CyLys Poly(EY) 7.4 (pD) 395c
9 CyLys Poly(EY) 7.3 (NaCl) 342b
10 CyLys Ac–YEEI–NH2 7.3 526
b
11 CyLys Ac–EEEIYEEFD–NH2 7.3 500
b
a Estimated statistical errorso15%. b Measured by fluorescence titration
of the Tyr containing peptide upon addition of the cage. c Measured by
NMR titration of the cage by addition of the peptide.
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showed similar binding constants but different shapes of the
emission spectra (Fig. S33 in the ESI†). Thus, the maximum at
450 nm is more intense at lower pH while the band at 375 nm
increases at higher pH, suggesting that the differences in
the titration with CyOrn or CyLys must be due to a higher
protonation degree of the complex formed with CyLys.
Spin-lock filtered NMR experiments17 were also employed
for studying the binding process in solution. This NMR tech-
nique uses the spin–lattice relaxation time in the rotating frame
(T1r) as the binding probe thanks to its dependence on the
correlation time. Thus, the relaxation of the cage is highly
enhanced upon binding to the poly(EY), leading to a decrease
in the intensity of the NMR signals in the T1r filtered
1H NMR
experiment. Accordingly, titration of CyOrn with poly(EY) in
D2O (75 mM deuterated Tris, pD 7.4) induced a decrease in the
intensity of many 1H NMR signals (Fig. 3C) implying an efficient
interaction in solution. Moreover, some signals from the cage also
shifted upon binding, mainly those corresponding to the aromatic
tripodal ring (H1) and the methylene close to the primary amine of
the side chains (Hd). The non-linear fitting of the variation of the
chemical shift of the H1 singlet rendered a Kd = 403 mM (Table 1,
entry 7), which is within the same order of the value obtained by
fluorescence spectroscopy. The experiments performed with CyLys
rendered parallel results and a comparable binding constant
(Table 1, entry 8 and ESI†). The 2D-NOESY experiment of amixture
of CyLys and poly(EY) (500 MHz, deuterated Tris buffer in D2O at
pD 7.4, Fig. S49 in the ESI†) showed an intermolecular cross-peak
between H1 of the cage and He of the Tyr residues of the peptide.
This NOE further supported the proposed binding in solution.
The CyLys cage was also able to bind to poly(EY) in the presence
of 150 mM NaCl (Table 1, entry 9), a more challenging solvent
for the interaction.
Considering that the prepared cages showed eﬃcient bind-
ing of the EYE peptide sequence in pure water at neutral pH, we
envisioned the possibility of the cages to protect the peptides
from the action of the PTK enzyme. To that, we used an in vitro
commercial assay for the evaluation of the eﬀect of the cages on
the phosphorylation reaction (assay description in the ESI†).18
We performed the experiments in the presence of the cages at
diﬀerent concentrations and the results were transformed into
the remaining percent of kinase activity by comparison with the
control experiment in the absence of cage (Fig. 4). Also CySer
and CyThr (Fig. 1) were included as controls, since both showed
very weak binding to the poly(EY) substrate in buﬀered water
(by NMR and fluorescence spectroscopy, see the ESI†). All the
cages were able to partially protect the substrates from the
tyrosine kinase phosphorylation, showing diﬀerences depending
on the cage structure and its concentration. The cages derived
from Ser and Thr displayed a modest protection, requiring a
high concentration (9 mM) to yield an B30% decrease of
phosphorylation. Since they showed practically no eﬀect at
1 mM, lower concentrations were not tested.
This low activity clearly correlates with their weaker binding
to the EYE motif. However, CyOrn and CyLys displayed inter-
esting competition with the PTK in the sub-millimolar range.
At concentration values (0.26–1.10 mM) close to the corresponding
Kd for the EYE-cage binding, the CyOrn host showed a 50–60%
decrease in the phosphorylation, which can be directly ascribed to
the cage-peptide recognition. Quite remarkably, a higher activity
was observed for CyLys, with B70% protection from the kinase
action in the 0.26–1.10 mM concentration range. These differences
are more evident at lower concentrations of the cages: for instance,
at 18 mM CyLysB50% protection was produced while CyOrn was
practically inactive (B100% of the remaining kinase activity, Fig. 4).
The longer side chains of the Lys derivative lead to amore positively
charged and more hydrophobic cage, which could produce a
multivalent effect in the binding process, especially for this assay
where the polypeptide substrate is anchored to a surface with
possible clustering of the supramolecular complexes. Thus, the
trends clearly reflect the validity of our proposal, since the cages
with a higher affinity for the EYE motif showed a more efficient
protection from the PTK-mediated phosphorylation reaction.
The modulation of the biochemical machinery with syn-
thetic molecules has become a common procedure to study
biological processes and, ideally, to design chemical tools for
the treatment of diseases. In these cases, ad hoc designed
synthetic molecules are prepared to bind large biomolecular
systems (usually proteins). Within this rational, the inhibition
of enzymatic activity has been normally faced by preparing
chemicals able to bind the catalytic site of the enzymes.12a Here
we demonstrated a complementary approach based on supra-
molecular chemistry. Thus, we have used the synthetic mole-
cule to bind the substrate of the enzyme instead of the enzyme
itself. This approach has been previously used to inhibit
proteases3c,f and a demethylase5e but, to the best of our knowl-
edge, it has never been used to modulate a kinase activity. This
host–guest approximation shows the advantage of allowing a
better implementation of substrate selectivity, in case the same
enzyme is implicated in the modification of different substrates
(as it is common for kinases). Despite the moderate potency of
our cages for a formal PTK inhibition, the supramolecular
Fig. 4 In vitro enzymatic phosphorylation assays: PTK catalyzed phos-
phorylation of the poly(EY) substrate in the presence of diﬀerent concen-
trations of the pseudopeptidic cages. The values show the average of two
independent experiments, each one in three replicated measurements,
with error bars showing the standard deviations.
ChemComm Communication
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 3
1 
M
ay
 2
01
6.
 D
ow
nl
oa
de
d 
on
 1
4/
06
/2
01
6 
09
:4
6:
31
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n-
N
on
Co
m
m
er
ci
al
 3
.0
 U
np
or
te
d 
Li
ce
nc
e.
View Article Online
Chem. Commun. This journal is©The Royal Society of Chemistry 2016
mechanism of action targeting the substrate of the enzyme will
open a new way for kinase activity modulation. The selectivity
needed for improving this supramolecular kinase modulation
can be tailored by structural modifications in the pseudopeptidic
cages, thus possibly targeting known phosphorylation consensus
sequences with specific characteristics.19 Thus, for instance, CyLys
also recognized two Tyr-containing peptides (entries 10 and 11 in
Table 1) that are target sequences of biologically relevant kinases,20
foreseeing the potential real applications of these cages.
In conclusion, the new pseudopeptidic cages described here
eﬃciently recognize the EYE peptide sequence in buﬀered
water, as shown by fluorescence and NMR spectroscopies.
The binding occurs both with the isolated tripeptide and when
the EYE motif forms part of a longer polypeptide chain as a
model of a biomacromolecule. This supramolecular interaction
eﬃciently protects the Tyr side chain from the enzymatic
phosphorylation, as shown by in vitro kinase assays. Besides,
the decrease in the phosphorylation degree can be roughly
correlated with the cage-EYE sequence aﬃnity. We believe that
our results have wide implications, since they open a way to use
supramolecular systems to modulate biochemical processes by
substrate recognition, thus possibly hiding the substrates from
their natural receptor or enzyme. A further generalization of
this concept is under study in our group.
This work was supported by MINECO/FEDER (CTQ2012-
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